BACKGROUND: Findings from in vivo research may be less reliable where studies do not report measures to reduce risks of bias. The experimental stroke community has been at the forefront of implementing changes to improve reporting, but it is not known whether these efforts are associated with continuous improvements. Our aims here were firstly to validate an automated tool to assess risks of bias in published works, and secondly to assess the reporting of measures taken to reduce the risk of bias within recent literature for two experimental models of stroke. METHODS: We developed and used text analytic approaches to automatically ascertain reporting of measures to reduce risk of bias from full-text articles describing animal experiments in...
Background and Purpose-The neutral results of the SAINT II trial have again highlighted difficulties...
An important factor for successful translational stroke research is study quality. Low-quality studi...
Background and Objectives: Randomization, allocation concealment, and blind outcome assessment have ...
BACKGROUND: Findings from in vivo research may be less reliable where studies do not report measures...
The consolidation of scientific knowledge proceeds through the interpretation and then distillation ...
BACKGROUND AND PURPOSE: As a research community, we have failed to demonstrate that drugs which show...
Background and Purpose - As a research community, we have failed to demonstrate that drugs which sho...
BACKGROUND AND PURPOSE: As a research community, we have failed to demonstrate that drugs which show...
As a research community, we have failed to demonstrate that drugs that show substantial efficacy in ...
As a research community, we have failed to demonstrate that drugs that show substantial efficacy in ...
As a research community, we have failed to show that drugs, which show substantial efficacy in anima...
Background and Purpose - At least part of the failure in the transition from experimental to clinica...
Background and Purpose—At least part of the failure in the transition from experimental to clinical ...
Background and Purpose: At least part of the failure in the transition from experimental to clinical...
Over the past decades, great progress has been made in clinical as well as experimental stroke resea...
Background and Purpose-The neutral results of the SAINT II trial have again highlighted difficulties...
An important factor for successful translational stroke research is study quality. Low-quality studi...
Background and Objectives: Randomization, allocation concealment, and blind outcome assessment have ...
BACKGROUND: Findings from in vivo research may be less reliable where studies do not report measures...
The consolidation of scientific knowledge proceeds through the interpretation and then distillation ...
BACKGROUND AND PURPOSE: As a research community, we have failed to demonstrate that drugs which show...
Background and Purpose - As a research community, we have failed to demonstrate that drugs which sho...
BACKGROUND AND PURPOSE: As a research community, we have failed to demonstrate that drugs which show...
As a research community, we have failed to demonstrate that drugs that show substantial efficacy in ...
As a research community, we have failed to demonstrate that drugs that show substantial efficacy in ...
As a research community, we have failed to show that drugs, which show substantial efficacy in anima...
Background and Purpose - At least part of the failure in the transition from experimental to clinica...
Background and Purpose—At least part of the failure in the transition from experimental to clinical ...
Background and Purpose: At least part of the failure in the transition from experimental to clinical...
Over the past decades, great progress has been made in clinical as well as experimental stroke resea...
Background and Purpose-The neutral results of the SAINT II trial have again highlighted difficulties...
An important factor for successful translational stroke research is study quality. Low-quality studi...
Background and Objectives: Randomization, allocation concealment, and blind outcome assessment have ...